NCT01986374 is a NA clinical trial of HCG is introduced in Infertility, sponsored by Servy Massey Fertility Insititute.

Who is sponsoring NCT01986374?

NCT01986374 is sponsored by Servy Massey Fertility Insititute.

What drugs are being tested in NCT01986374?

Interventions in NCT01986374: HCG is introduced.

What condition does NCT01986374 study?

NCT01986374 studies Infertility.

Is NCT01986374 still recruiting?

NCT01986374 is currently completed. Last updated 17 March 2020.

Last reviewed 2020-03-17 · How we verify

NCT01986374

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intrauterine Injection of Human Chorionic Gonadotropin to Enhance Embryo Implantation

Completed NA Last updated 17 March 2020

What this trial tests

NA trial testing HCG is introduced in Infertility in 75 participants. Completed in 1 February 2016.

Timeline

1 June 2013

Primary endpoint
1 December 2015

1 February 2016

Quick facts

Lead sponsor	Servy Massey Fertility Insititute
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	75
Start date	1 June 2013
Primary completion	1 December 2015
Estimated completion	1 February 2016
Sites	1 location across United States

Drugs / interventions tested

HCG is introduced — full drug profile →

Conditions studied

Infertility — all drugs for Infertility →

Sponsor

Servy Massey Fertility Insititute — full company profile →

Who can join

Adults 21 to 47, female only, with Infertility. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

HCG enhances pregnancy rate
Time frame: 9 months.
compare pregnancy rates to established clinical norms.

Sponsor's own description

The endometrium is deprived of signals form the embryo in IVF conditions. Studies suggest that placing HCG into the uterus prior to embryo transfer can enhance implantation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Infertility

Currently open trials in the same condition.

NCT07074015 — IntelliWell: An AI-Assisted Imaging Platform for Detection and Location of Ultra-Rare Testicular Sperm in Surgical Speci · NA · recruiting
NCT07358468 — Impact Of FET Preparation Protocol On Endometrial Peristalsis: A Prospective Cohort Study · recruiting
NCT07340827 — A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH · Phase 3 · recruiting
NCT07369362 — To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That · NA · active not recruiting
NCT07153367 — Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauter · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01986374 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Servy Massey Fertility Insititute
Last refreshed: 17 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01986374.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing